The advantages of using triple-marker screening for chromosomal abnormalities

Keyphrases

• Chromosomal Abnormalities 100%
• Marker Screening 100%
• Triple Marker 100%
• Trisomy 21 66%
• Amniocentesis 66%
• Unconjugated Estriol 66%
• Screen Positive 66%
• Multiple of the Median 50%
• False Positive Rate 50%
• Alpha-fetoprotein 33%
• 46,XX 33%
• Maternal Age 33%
• Human Chorionic Gonadotropin 33%
• Maternal Serum Screening 33%
• 45,X 33%
• Screening Program 33%
• Screening Test 16%
• Detection Rate 16%
• Serological Screening 16%
• Second Trimester 16%
• Trisomy 18 16%
• 47,XYY 16%
• 47,XXY 16%
• Positive Rate 16%

Medicine and Dentistry

• Chromosome Aberration 100%
• Trisomy 21 66%
• Amniocentesis 66%
• Estriol 66%
• False Positive Result 50%
• Multiple of the Median 50%
• Fetoprotein 33%
• Maternal Age 33%
• Maternal Serum 33%
• Chorionic Gonadotropin 33%
• Screening Program 33%
• Karyotype 16%
• Screening Test 16%
• Isoprenaline 16%
• Trisomy 18 16%
• Second Trimester Pregnancy 16%
• Trisomy 16%
• Karyotype 45,X 16%
• 47,XXY Syndrome 16%

Biochemistry, Genetics and Molecular Biology

• Chromosomal Abnormalities 100%
• Trisomy 21 66%
• Maternal Age 33%
• Human Chorionic Gonadotropin 33%
• Karyotype 16%
• Screening Test 16%
• Second Trimester Pregnancy 16%
• Trisomy 18 16%
• Trisomy 16%
• Karyotype 47,XXY 16%
• Karyotype 45,X 16%
• Isoprenaline 16%